Clinical Trials Browser

Terminated × Carcinoma, Pancreatic Ductal × Capecitabine × Clear all

NCT02243007 2017-05-16

Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer

Phase 2 Terminated

7 enrolled 8 charts

Gastrointestinal

Carcinoma, Pancreatic Ductal